The estimated Net Worth of Raphael Wisniewski is at least $219 Milione dollars as of 17 January 2020. Raphael Wisniewski owns over 300,000 units of Axonics Inc stock worth over $203,266,295 and over the last 6 years Raphael sold AXNX stock worth over $15,681,000.
Raphael has made over 3 trades of the Axonics Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently Raphael sold 300,000 units of AXNX stock worth $9,459,000 on 17 January 2020.
The largest trade Raphael's ever made was buying 866,666 units of Axonics Inc stock on 2 November 2018 worth over $12,999,990. On average, Raphael trades about 488,889 units every 147 days since 2018. As of 17 January 2020 Raphael still owns at least 2,957,461 units of Axonics Inc stock.
You can see the complete history of Raphael Wisniewski stock trades at the bottom of the page.
Raphael's mailing address filed with the SEC is 26, Technology Drive, Irvine Spectrum, Irvine, Orange County, California, 92618, United States.
Over the last 6 years, insiders at Axonics Inc have traded over $108,010,643 worth of Axonics Inc stock and bought 4,672,163 units worth $70,180,620 . The most active insiders traders include Asset Management, Lp Chen B..., Shahzad Malik e Geoff Pardo. On average, Axonics Inc executives and independent directors trade stock every 15 days with the average trade being worth of $4,280,711. The most recent stock trade was executed by Raymond W Cohen on 24 July 2024, trading 103,896 units of AXNX stock currently worth $2,383,374.
axonics modulation technologies, inc is a privately-held medical device company developing an innovative neuromodulation platform based on a miniaturized rechargeable fully-implantable ipg licensed from the alfred mann foundation. the axonics sacral neuromodulation system is designed to improve the experience of both clinicians and patients suffering from urinary and fecal dysfunction.
Axonics Inc executives and other stock owners filed with the SEC include: